BRAF mutations are rare in biliary tract cancers (BTCs), predominantly found in intrahepatic cholangiocarcinomas (iCCAs) with an overall incidence of about 5% to 7% [33]. The gene discussed is BRAF; the disease is biliary tract neoplasm.